KHRNF.US Khiron Life Sciences Corp

Healthcare Pharmaceuticals USA Stocks
0.0000 USD
Close of Nov 14, 2026
Market cap
USD 2.32K
P/E
-
P/B
0.00x
ROE
-54.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2022.

Is KHRNF.US undervalued?

Graham number

The Graham number of Khiron Life Sciences Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Khiron Life Sciences Corp fundamental analysis

No fundamental analysis for Khiron Life Sciences Corp yet.

Khiron Life Sciences Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Khiron Life Sciences Corp

Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells its products in Colombia, Peru, Germany, the United Kingdom, B…

Full company profile